FTC wants more from Steris, Synergy on inversion merger

January 12, 2015 By Brad Perriello Leave a Comment

BD owes $340m to Retractable Technologies in anti-trust case

November 11, 2014 By Brad Perriello Leave a Comment

Medtronic offers EU concessions in $43 billion Covidien deal

November 11, 2014 By MassDevice Leave a Comment

EuroZone anti-trust regulators to rule next month on $43B Covidien buy

October 14, 2014 By Brad Perriello Leave a Comment

BD loses bid to overturn $114m antitrust loss to Retractable Technologies

October 8, 2014 By Brad Perriello Leave a Comment

Appeals court reverses Medtronic’s win in Lenox bone mill spat

August 11, 2014 By Arezu Sarvestani Leave a Comment

Appeals court reverses Medtronic's win in bone mill spat

Lenox MacLaren Surgical is dragging Medtronic (NYSE:MDT) back into the courtroom after an appeals court ruled that Lenox has grounds to make its case against the medical device giant.

Diabetes: UniStrip levels anti-trust charges against Johnson & Johnson’s LifeScan

July 9, 2014 By Brad Perriello Leave a Comment

China fines J&J and other contact lens makers for anti-trust violations

May 30, 2014 By Arezu Sarvestani Leave a Comment

China fines contact lens makers for anti-trust violations

Chinese regulators slapped a string of contact lens and eyeglass makers with more than $3 million (19 million yuan) in fines after accusing them of violating the country’s anti-trust laws.

Legal: Becton appeals $114M antitrust loss to Retractable Technologies

October 17, 2013 By Arezu Sarvestani Leave a Comment

Becton hopes to reverse $114M Retractable Technologies antitrust win

Retractable Technologies claims $114M win over Becton Dickinson in anti-trust lawsuit

September 20, 2013 By Brad Perriello Leave a Comment

Retractable Technologies claims win over Becton Dickinson in anti-trust lawsuit

Baxter can question FDA official in plasma therapy price-fixing case

September 19, 2013 By Brad Perriello Leave a Comment

Baxter can compel FDA testimony in plasma MDL

A federal judge granted Baxter‘s (NYSE:BAX) bid to force an FDA official to testify in the multi-district litigation accusing it of taking part in a price-fixing scheme for plasma therapy.